Zhihao Ding, PhD
Head of Human Genetics
Dr. Zhihao Ding was trained in his PhD at the Wellcome Trust Sanger Institute, the University of Cambridge, studying the genetics of cellular traits and genomic algorithms. He had a Postdoc at the Wellcome Trust Centre for Human Genetics, University of Oxford, studying the genetics of rare diseases and cancers. In 2015, he transitioned to industry working at Genomics PLC, Oxford, UK, where he developed algorithmic solutions and products for rare disease diagnostics. He led work packages for a panel of pharmaceutical companies in evaluating specific targets in disease areas of therapeutic interests. Before joining Boehringer Ingelheim (BI), Dr. Zhihao was leading target projects on NASH at Novo Nordisk Research Centre Oxford (NNRCO). Dr. Zhihao was one of the first genetic scientists joined the NNRCO, where he helped build the genetic capacity and initiated several academic research collaborations with the Big Data Institute, University of Oxford. Dr. Zhihao joined BI as the Head of Human Genetics in July 2020, where he’s leading genetic initiatives in gCBDS.